The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Redox‐Active Metal Complexes for Anticancer Therapy
Open accessAbstract
The redox properties of both metals and ligands in transition metal complexes offer unusual routes for new mechanisms of anticancer therapy. Metal complexes can introduce artificial reductive and oxidative stress into cancer cells, including behavior as photoactivatable agents and catalysts. Relatively inert metal complexes (“prodrugs”) can be activated by redox processes within cancer cells. Examples of pharmaceuticals activated by bioreduction include three Pt IV and two Ru III compounds that have already entered clinical trials. More recently, novel Co III, Fe III, Pt IV, Ru(III/II), Os II, and Ir III complexes have been reported to exhibit redox‐mediated anticancer activity. Redox activation strategies can introduce new methods to increase cancer cell selectivity and combat drug resistance. Using combination therapy together with redox modulators to increase potency is also possible. This essay focuses on metal complexes that are activated in the reducing environment of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free Radicals in Biology and Medicine
Halliwell, B., & Gutteridge, J. M. C. (2015) · doi:10.1093/acprof:oso/9780198717478.001.0001 · Cited by 8,990
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Schafer, F. Q., & Buettner, G. R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00480-4 · Cited by 4,587
Nordberg, J., & Arnér, E. S. J. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00724-9 · Cited by 2,662
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00597 · Cited by 2,485
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
Bhattacharyya, A., Chattopadhyay, R., Mitra, S., & Crowe, S. E. (2014) · Physiological Reviews · doi:10.1152/physrev.00040.2012 · Cited by 2,484
Cisplatin Nephrotoxicity: A Review
Yao, X., Panichpisal, K., Kurtzman, N., & Nugent, K. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31812dfe1e · Cited by 1,251
Hartinger, C. G., Jakupec, M. A., Zorbas‐Seifried, S., Groessl, M., Egger, A., Berger, W., Zorbas, H., Dyson, P. J., & Keppler, B. K. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890195 · Cited by 830
Inhibition of Cancer Cell Growth by Ruthenium(II) Arene Complexes
Morris, R. E., Aird, R. E., del Socorro Murdoch, P., Chen, H., Cummings, J., Hughes, N. D., Parsons, S., Parkin, A., Boyd, G., Jodrell, D. I., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010051m · Cited by 787
Self-citationIn Vitro and in Vivo Evaluation of Ruthenium(II)−Arene PTA Complexes
Scolaro, C., Bergamo, A., Brescacín, L., Delfino, R., Cocchietto, M., Laurenczy, G., Geldbach, T. J., Sava, G., & Dyson, P. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050015d · Cited by 784
Galanski, M. S., Jakupec, M. A., & Keppler, B. K. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054637626 · Cited by 721
Platinum(IV) antitumour compounds: their bioinorganic chemistry
Hall, M. D., & Hambley, T. W. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00026-7 · Cited by 622
Role of Oxidative Stress and Molecular Changes in Liver Fibrosis: A Review
Sanchez-Valle, V., C. Chavez-Tapia, N., Uribe, M., & Mendez-Sanchez, N. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803341520 · Cited by 593
Organoiridium Complexes: Anticancer Agents and Catalysts
Liu, Z., & Sadler, P. J. (2014) · Accounts of Chemical Research · doi:10.1021/ar400266c · Cited by 573
Self-citationTumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies
Shannon, A. M., Bouchier-Hayes, D. J., Condron, C. M., & Toomey, D. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)00003-3 · Cited by 559
Anticancer Activity of Metal Complexes: Involvement of Redox Processes
Jungwirth, U., Kowol, C. R., Keppler, B. K., Hartinger, C. G., Berger, W., & Heffeter, P. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3663 · Cited by 554
Pulmonary Strategies of Antioxidant Defense
Heffner, J. E., & Repine, J. E. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.2.531 · Cited by 540
Redox activation of metal-based prodrugs as a strategy for drug delivery
Graf, N., & Lippard, S. J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.007 · Cited by 523
Redox Reactions and Microbial Killing in the Neutrophil Phagosome
Winterbourn, C. C., & Kettle, A. J. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4827 · Cited by 468
Next-Generation Metal Anticancer Complexes: Multitargeting via Redox Modulation
Romero-Canelón, I., & Sadler, P. J. (2013) · Inorganic Chemistry · doi:10.1021/ic400835n · Cited by 396
Self-citationLeijen, S., Burgers, S. A., Baas, P., Pluim, D., Tibben, M., van Werkhoven, E., Alessio, E., Sava, G., Beijnen, J. H., & Schellens, J. H. M. (2015) · Investigational New Drugs · doi:10.1007/s10637-014-0179-1 · Cited by 374
Organometallic Half-Sandwich Iridium Anticancer Complexes
Liu, Z., Habtemariam, A., Pizarro, A. M., Fletcher, S. A., Kisova, A., Vrana, O., Salassa, L., Bruijnincx, P. C. A., Clarkson, G. J., Brabec, V., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2000932 · Cited by 357
Self-citationThe Potent Oxidant Anticancer Activity of Organoiridium Catalysts
Liu, Z., Romero‐Canelón, I., Qamar, B., Hearn, J. M., Habtemariam, A., Barry, N. P. E., Pizarro, A. M., Clarkson, G. J., & Sadler, P. J. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201311161 · Cited by 345
Self-citationAdvances in cobalt complexes as anticancer agents
Munteanu, C. R., & Suntharalingam, K. (2015) · Dalton Transactions · doi:10.1039/c5dt02101d · Cited by 330
Metal-based drugs that break the rules
Allardyce, C. S., & Dyson, P. J. (2016) · Dalton Transactions · doi:10.1039/c5dt03919c · Cited by 308
Catalytic organometallic anticancer complexes
Dougan, S. J., Habtemariam, A., McHale, S. E., Parsons, S., & Sadler, P. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800076105 · Cited by 303
Self-citationA potent cytotoxic photoactivated platinum complex
Mackay, F. S., Woods, J. A., Heringová, P., Kašpárková, J., Pizarro, A. M., Moggach, S. A., Parsons, S., Brabec, V., & Sadler, P. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707742105 · Cited by 303
Self-citationThioredoxin System in Cell Death Progression
Lu, J., & Holmgren, A. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4650 · Cited by 279
Advances in Platinum Chemotherapeutics
Harper, B. W., Krause‐Heuer, A. M., Grant, M. P., Manohar, M., Garbutcheon‐Singh, K. B., & Aldrich‐Wright, J. R. (2010) · Chemistry – A European Journal · doi:10.1002/chem.201000148 · Cited by 267
Redox Control of Asthma: Molecular Mechanisms and Therapeutic Opportunities
Comhair, S. A. A., & Erzurum, S. C. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2425 · Cited by 246
Tumor Microenvironment and the Response to Anticancer Therapy
Brown, J. M. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.5.157 · Cited by 232
Romero-Canelón, I., Salassa, L., & Sadler, P. J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3017442 · Cited by 221
Self-citationActivation Mechanisms for Organometallic Anticancer Complexes
Pizarro, A. M., Habtemariam, A., & Sadler, P. J. (2010) · Topics in Organometallic Chemistry · doi:10.1007/978-3-642-13185-1_2 · Cited by 199
Self-citationElectron-transfer activated metal-based anticancer drugs
Reisner, E., Arion, V. B., Keppler, B. K., & Pombeiro, A. J. L. (2008) · Inorganica Chimica Acta · doi:10.1016/j.ica.2006.12.005 · Cited by 197
Rhodium(III) and iridium(III) complexes as anticancer agents
Geldmacher, Y., Oleszak, M., & Sheldrick, W. S. (2012) · Inorganica Chimica Acta · doi:10.1016/j.ica.2012.06.046 · Cited by 194
Ware, D. C., Palmer, B. D., Wilson, W. R., & Denny, W. A. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00065a006 · Cited by 193
Betanzos‐Lara, S., Liu, Z., Habtemariam, A., Pizarro, A. M., Qamar, B., & Sadler, P. J. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201108175 · Cited by 189
Self-citationDevelopment of anticancer agents: wizardry with osmium
Hanif, M., Babak, M. V., & Hartinger, C. G. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.016 · Cited by 172
Wang, F., Xu, J., Habtemariam, A., Bella, J., & Sadler, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053387k · Cited by 169
Self-citationAwuah, S. G., Zheng, Y.-R., Bruno, P. M., Hemann, M. T., & Lippard, S. J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b10182 · Cited by 164
Chow, M. J., Licona, C., Yuan Qiang Wong, D., Pastorin, G., Gaiddon, C., & Ang, W. H. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500455p · Cited by 159
Delivery and release of curcumin by a hypoxia-activated cobalt chaperone: a XANES and FLIM study
Renfrew, A. K., Bryce, N. S., & Hambley, T. W. (2013) · Chemical Science · doi:10.1039/c3sc51530c · Cited by 149
Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C∧N-Chelated and Pyridine Ligands
Liu, Z., Romero‐Canelón, I., Habtemariam, A., Clarkson, G. J., & Sadler, P. J. (2014) · Organometallics · doi:10.1021/om500644f · Cited by 148
Self-citationFailes, T. W., Cullinane, C. M., Diakos, C. I., Yamamoto, N., Lyons, J. G., & Hambley, T. W. (2006) · Chemistry - A European Journal · doi:10.1002/chem.200601137 · Cited by 143
Organometallic Osmium Arene Complexes with Potent Cancer Cell Cytotoxicity
Fu, Y., Habtemariam, A., Pizarro, A. M., van Rijt, S., Healey, D. J., Cooper, P. A., Shnyder, S. D., Clarkson, G. J., & Sadler, P. J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100560f · Cited by 132
Self-citationGlutathione S-conjugates as prodrugs to target drug-resistant tumors
Ramsay, E. E., & Dilda, P. J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00181 · Cited by 129
Gandioso, A., Shaili, E., Massaguer, A., Artigas, G., González-Cantó, A., Woods, J. A., Sadler, P. J., & Marchán, V. (2015) · Chemical Communications · doi:10.1039/c5cc03180j · Cited by 116
Self-citationDual Targeting of Hypoxic and Acidic Tumor Environments with a Cobalt(III) Chaperone Complex
Yamamoto, N., Renfrew, A. K., Kim, B. J., Bryce, N. S., & Hambley, T. W. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3014713 · Cited by 101
Fu, Y., Romero, M. J., Habtemariam, A., Snowden, M. E., Song, L., Clarkson, G. J., Qamar, B., Pizarro, A. M., Unwin, P. R., & Sadler, P. J. (2012) · Chemical Science · doi:10.1039/c2sc20220d · Cited by 101
Self-citationSánchez-Cano, C., Romero‐Canelón, I., Yang, Y., Hands-Portman, I., Bohic, S., Cloetens, P., & Sadler, P. J. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201605911 · Cited by 94
Self-citationThe Potent Oxidant Anticancer Activity of Organoiridium Catalysts
Liu, Z., Romero‐Canelón, I., Qamar, B., Hearn, J. M., Habtemariam, A., Barry, N. P. E., Pizarro, A. M., Clarkson, G. J., & Sadler, P. J. (2014) · Angewandte Chemie · doi:10.1002/ange.201311161 · Cited by 90
Self-citationEnhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation
Romero‐Canelón, I., Mos, M., & Sadler, P. J. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00655 · Cited by 89
Self-citationIn‐Cell Activation of Organo‐Osmium(II) Anticancer Complexes
Needham, R. J., Sánchez-Cano, C., Zhang, X., Romero‐Canelón, I., Habtemariam, A., Cooper, M. S., Meszaros, L. K., Clarkson, G. J., Blower, P. J., & Sadler, P. J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201610290 · Cited by 86
Self-citationChow, M. J., Licona, C., Pastorin, G., Mellitzer, G., Ang, W. H., & Gaiddon, C. (2016) · Chemical Science · doi:10.1039/c6sc00268d · Cited by 83
Fu, Y., Habtemariam, A., Basri, A. M., Braddick, D., Clarkson, G. J., & Sadler, P. J. (2011) · Dalton Transactions · doi:10.1039/c1dt10937e · Cited by 79
Self-citationModels of hypoxia activated prodrugs: Co(iii) complexes of hydroxamic acids
Failes, T. W., & Hambley, T. W. (2006) · Dalton Transactions · doi:10.1039/b512322d · Cited by 76
Anti-colorectal cancer activity of an organometallic osmium arene azopyridine complex
Shnyder, S. D., Fu, Y., Habtemariam, A., van Rijt, S., Cooper, P. A., Loadman, P. M., & Sadler, P. J. (2011) · MedChemComm · doi:10.1039/c1md00075f · Cited by 69
Self-citationA Novel Design Strategy for Stable Metal Complexes of Nitrogen Mustards as Bioreductive Prodrugs
Parker, L. L., Lacy, S. M., Farrugia, L. J., Evans, C., Robins, D. J., O’Hare, C. C., Hartley, J. A., Jaffar, M., & Stratford, I. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049866w · Cited by 60
Redox-Regulated Mechanisms in Asthma
Hoshino, T., Okamoto, M., Takei, S., Sakazaki, Y., Iwanaga, T., & Aizawa, H. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1936 · Cited by 53
Failes, T. W., & Hambley, T. W. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.11.003 · Cited by 47
Oxidation induced by the antioxidant glutathione (GSH)
Petzold, H., & Sadler, P. J. (2008) · Chemical Communications · doi:10.1039/b805358h · Cited by 43
Self-citationAldib, I., Soubhye, J., Boudjeltia, K. Z., Vanhaeverbeek, M., Rousseau, A., Furtmüller, P. G., Obinger, C., Dufrasne, F., Nève, J., Antwerpen, P. V., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3007245 · Cited by 38
A Photoactivatable Platinum(IV) Anticancer Complex Conjugated to the RNA Ligand Guanidinoneomycin
Shaili, E., Fernández-Giménez, M., Rodríguez-Astor, S., Gandioso, A., Sandín, L., García-Vélez, C., Massaguer, A., Clarkson, G. J., Woods, J. A., Sadler, P. J., et al. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201502373 · Cited by 28
Self-citationSpin-labelled photo-cytotoxic diazido platinum( iv ) anticancer complex
Venkatesh, V., Wedge, C. J., Romero‐Canelón, I., Habtemariam, A., & Sadler, P. J. (2016) · Dalton Transactions · doi:10.1039/c6dt01382a · Cited by 22
Self-citationFishel, M. L., Gamcsik, M. P., Delaney, S. M., Zuhowski, E. G., Maher, V. M., Karrison, T. G., Moschel, R. C., Egorin, M. J., & Dolan, M. E. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0901-3 · Cited by 18
Sabuncuoğlu, S., Eken, A., Aydın, A., Özgüneş, H., & Orhan, H. (2014) · Drug and Chemical Toxicology · doi:10.3109/01480545.2014.974107 · Cited by 12
In‐Cell Activation of Organo‐Osmium(II) Anticancer Complexes
Needham, R. J., Sánchez-Cano, C., Zhang, X., Romero‐Canelón, I., Habtemariam, A., Cooper, M. S., Meszaros, L. K., Clarkson, G. J., Blower, P. J., & Sadler, P. J. (2016) · Angewandte Chemie · doi:10.1002/ange.201610290 · Cited by 11
Self-citation
Cited by
Metallodrugs are unique: opportunities and challenges of discovery and development
Anthony, E. J., Bolitho, E. M., Bridgewater, H. E., Carter, O. W. L., Donnelly, J. M., Imberti, C., Lant, E. C., Lermyte, F., Needham, R. J., Palau, M., et al. (2020) · Chemical Science · doi:10.1039/d0sc04082g · Cited by 692
Self-citationStimuli-Responsive Therapeutic Metallodrugs
Wang, X., Wang, X., Jin, S., Muhammad, N., & Guo, Z. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00209 · Cited by 649
New Antimicrobial Strategies Based on Metal Complexes
Claudel, M., Schwarte, J. V., & Fromm, K. M. (2020) · Chemistry · doi:10.3390/chemistry2040056 · Cited by 344
Metadata
- Authors
- Zhang, P., & Sadler, P. J.
- Venue
- European Journal of Inorganic Chemistry
- Publisher
- Wiley
- Published
- 2017-03
- Volume
- 2017
- Issue
- 12
- Pages
- 1541-1548
- ISSN
- 1099-0682 (ISSN-L)
- 1434-1948
- OpenAlex
- W2593621757
- Cited by
- 274
- References
- 69
- FWCI
- 11.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.